AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $330,000 | +432.3% | 53,900 | +107.3% | 0.02% | +433.3% |
Q2 2021 | $62,000 | -80.9% | 26,000 | -63.3% | 0.00% | -87.0% |
Q1 2021 | $325,000 | +10.5% | 70,776 | -20.7% | 0.02% | -11.5% |
Q4 2020 | $294,000 | +14.8% | 89,200 | +187.7% | 0.03% | +18.2% |
Q4 2019 | $256,000 | – | 31,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |